Literature DB >> 26769414

Comparison of Steroid Modulation of Spontaneous Inhibitory Postsynaptic Currents in Cultured Hippocampal Neurons and Steady-State Single-Channel Currents from Heterologously Expressed α1β2γ2L GABA(A) Receptors.

Sampurna Chakrabarti1, Mingxing Qian1, Kathiresan Krishnan1, Douglas F Covey1, Steven Mennerick1, Gustav Akk2.   

Abstract

Neuroactive steroids are efficacious modulators of γ-aminobutyric acid type A receptor (GABA(A)) receptor function. The effects of steroids on the GABA(A) receptor are typically determined by comparing steady-state single-channel open probability or macroscopic peak responses elicited by GABA in the absence and presence of a steroid. Due to differences in activation conditions (exposure duration, concentration of agonist), it is not obvious whether modulation measured using typical experimental protocols can be used to accurately predict the effect of a modulator on native receptors under physiologic conditions. In the present study, we examined the effects of 14 neuroactive steroids and analogs on the properties of spontaneous inhibitory postsynaptic currents (sIPSCs) in cultured rat hippocampal neurons. The goal was to determine whether the magnitude of modulation of the decay time course of sIPSCs correlates with the extent of modulation and kinetic properties of potentiation as determined in previous single-channel studies. The steroids were selected to cover a wide range of efficacy on heterologously expressed rat α1β2γ2L GABA(A) receptors, ranging from essentially inert to highly efficacious (strong potentiators of single-channel and macroscopic peak responses). The data indicate a strong correlation between prolongation of the decay time course of sIPSCs and potentiation of single-channel open probability. Furthermore, changes in intracluster closed time distributions were the single best predictor of prolongation of sIPSCs. We infer that the information obtained in steady-state single-channel recordings can be used to forecast modulation of synaptic currents.
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26769414      PMCID: PMC4809306          DOI: 10.1124/mol.115.102202

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  35 in total

1.  A high-performance liquid chromatography-tandem mass spectrometric method for the determination of pharmacokinetics of ganaxolone in rat, monkey, dog and human plasma.

Authors:  K Ram; G N Lam; B Chien
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2001-02-10

2.  Desensitized states prolong GABAA channel responses to brief agonist pulses.

Authors:  M V Jones; G L Westbrook
Journal:  Neuron       Date:  1995-07       Impact factor: 17.173

3.  Modulation of GABA(A) receptor channel gating by pentobarbital.

Authors:  J H Steinbach; G Akk
Journal:  J Physiol       Date:  2001-12-15       Impact factor: 5.182

4.  Modulation of GABAA receptor-mediated IPSCs by neuroactive steroids in a rat hypothalamo-hypophyseal coculture model.

Authors:  P Poisbeau; P Feltz; R Schlichter
Journal:  J Physiol       Date:  1997-04-15       Impact factor: 5.182

5.  Neurosteroid analogues. 17. Inverted binding orientations of androsterone enantiomers at the steroid potentiation site on γ-aminobutyric acid type A receptors.

Authors:  Kathiresan Krishnan; Brad D Manion; Amanda Taylor; John Bracamontes; Joseph H Steinbach; David E Reichert; Alex S Evers; Charles F Zorumski; Steven Mennerick; Douglas F Covey
Journal:  J Med Chem       Date:  2012-01-18       Impact factor: 7.446

6.  Multiple effects of allopregnanolone on GABAergic responses in single hippocampal CA3 pyramidal neurons.

Authors:  Hye-Mi Park; In-Sun Choi; Michiko Nakamura; Jin-Hwa Cho; Maan-Gee Lee; Il-Sung Jang
Journal:  Eur J Pharmacol       Date:  2010-11-29       Impact factor: 4.432

7.  Modes and models of GABA(A) receptor gating.

Authors:  Gareth M C Lema; Anthony Auerbach
Journal:  J Physiol       Date:  2006-02-02       Impact factor: 5.182

8.  A steroid anesthetic prolongs inhibitory postsynaptic currents in cultured rat hippocampal neurons.

Authors:  N L Harrison; S Vicini; J L Barker
Journal:  J Neurosci       Date:  1987-02       Impact factor: 6.167

9.  Dual actions of volatile anesthetics on GABA(A) IPSCs: dissociation of blocking and prolonging effects.

Authors:  M I Banks; R A Pearce
Journal:  Anesthesiology       Date:  1999-01       Impact factor: 7.892

10.  Natural and enantiomeric etiocholanolone interact with distinct sites on the rat alpha1beta2gamma2L GABAA receptor.

Authors:  Ping Li; John Bracamontes; Bryson W Katona; Douglas F Covey; Joe Henry Steinbach; Gustav Akk
Journal:  Mol Pharmacol       Date:  2007-03-06       Impact factor: 4.436

View more
  4 in total

1.  Enhanced GABAergic actions resulting from the coapplication of the steroid 3α-hydroxy-5α-pregnane-11,20-dione (alfaxalone) with propofol or diazepam.

Authors:  Lily Q Cao; Michael C Montana; Allison L Germann; Daniel J Shin; Sampurna Chakrabarti; Steven Mennerick; Carla M Yuede; David F Wozniak; Alex S Evers; Gustav Akk
Journal:  Sci Rep       Date:  2018-07-09       Impact factor: 4.379

2.  Neurosteroids as novel antidepressants and anxiolytics: GABA-A receptors and beyond.

Authors:  Charles F Zorumski; Steven M Paul; Douglas F Covey; Steven Mennerick
Journal:  Neurobiol Stress       Date:  2019-09-27

3.  Steady-state activation and modulation of the synaptic-type α1β2γ2L GABAA receptor by combinations of physiological and clinical ligands.

Authors:  Allison L Germann; Spencer R Pierce; Thomas C Senneff; Ariel B Burbridge; Joe Henry Steinbach; Gustav Akk
Journal:  Physiol Rep       Date:  2019-09

4.  Site-specific effects of neurosteroids on GABAA receptor activation and desensitization.

Authors:  Yusuke Sugasawa; Wayland Wl Cheng; John R Bracamontes; Zi-Wei Chen; Lei Wang; Allison L Germann; Spencer R Pierce; Thomas C Senneff; Kathiresan Krishnan; David E Reichert; Douglas F Covey; Gustav Akk; Alex S Evers
Journal:  Elife       Date:  2020-09-21       Impact factor: 8.140

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.